首页> 美国卫生研究院文献>other >Metachronous EBV-associated B-cell and T-cell Posttransplant Lymphoproliferative Disorders in a Heart Transplant Recipient
【2h】

Metachronous EBV-associated B-cell and T-cell Posttransplant Lymphoproliferative Disorders in a Heart Transplant Recipient

机译:心脏移植接受者中与EBV相关的B细胞和T细胞移植后的淋巴组织增生异常

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Posttransplant lymphoproliferative disorders (PTLDs) may occur as a complication of immunosuppression in patients who have received solid organ or bone marrow allografts. Most PTLDs are of B-cell lineage, whereas T-cell proliferations are rare. The majority of B-cell lesions are associated with Epstein-Barr virus infection. The occurrence of both B-cell and T-cell PTLDs in the same patient is extremely rare and only 6 cases have been previously published. We report a case of a 63-year-old man who developed 2 metachronous Epstein-Barr virus-related PTLDs beginning 10 years after heart transplantation. A polymorphic B-cell PTLD developed first that completely regressed after immunosuppressive therapy was partially with-drawn. Then, a monomorphic T-cell PTLD developed 31 months later. The patient died 17 months later owing to disease progression. We highlight the diagnostic challenge of this case that required numerous ancillary studies for lineage assessment and classification. Such studies are often needed in patients with a history of immunosuppression.
机译:接受实体器官或骨髓同种异体移植的患者,移植后淋巴细胞增生性疾病(PTLD)可能是免疫抑制的并发症。大多数PTLD属于B细胞谱系,而T细胞增殖很少见。大多数B细胞病变与Epstein-Barr病毒感染有关。同一患者中B细胞和T细胞PTLD的发生极为罕见,以前仅发表过6例。我们报道了一名63岁男子的案例,该人在心脏移植后10年开始发展出2个异时爱泼斯坦-巴尔病毒相关的PTLD。首先发展出多态性的B细胞PTLD,在免疫抑制治疗被部分撤回后完全退化。然后,在31个月后开发出了单态T细胞PTLD。该患者由于疾病进展而在17个月后死亡。我们强调了这种情况的诊断挑战,需要对谱系评估和分类进行大量辅助研究。有免疫抑制史的患者经常需要进行此类研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号